Gelsectan

DEVICE2 trials

Sponsors

Consorci Sanitari de l'Alt Penedès i Garraf, University Medical Center Ho Chi Minh City (UMC)

Conditions

Covert Hepatic EncephalopathyDiarrhea-predominant Irritable Bowel SyndromeIrritable Bowel Syndrome of Diarrhea Type (IBS-D)

Unknown Phase

GELSECTAN® and Covert Hepatic Encephalopathy

WithdrawnNCT05189834

Consorci Sanitari de l'Alt Penedès i GarrafCovert Hepatic Encephalopathy

Start: 2022-03-11End: 2022-07-30Updated: 2024-02-28

Evaluation of the Efficacy and Safety of Gelsectan in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome

RecruitingNCT07000383

University Medical Center Ho Chi Minh City (UMC)Diarrhea-predominant Irritable Bowel Syndrome, Irritable Bowel Syndrome of Diarrhea Type (IBS-D)

Start: 2025-06-15End: 2026-07-31Target: 90Updated: 2026-05-27